Galena Biopharma, Inc.

NASDAQ: GALE
$0.26
-$0.01 (-5.1%)
Closing price December 29, 2017
investor research

Top Analyst Upgrades and Downgrades: FireEye, Fresh Market, Galena, Peabody and More

Stocks are challenging all-time highs, and this is a shortened week due to Thanksgiving. Investors have to start positioning their assets and portfolios for 2014. 24/7 Wall St. reviews dozens ...
Read Full Story »
biotech

New Top Stocks to Buy Under $10 with Big Upside

The Wall Street firms that handle the bulk of retail accounts are always very careful about recommending stocks priced in the single digits. Typically they are fallen angels, or sometimes ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Chesapeake, Citigroup, Monster and More

Investors and traders are always looking for new research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find ...
Read Full Story »
stock symbol ticker

Stock Market Today: Big Winners & Losers for Thursday

Here are the five biggest gaining stocks in today’s U.S. markets at closing: Imperial Holdings Inc. (NYSE: IFT) is up 40.5% at $5.59. Kingtone WirelessInfo Solution Holding Ltd. (NASDAQ: KONE) ...
Read Full Story »
Wall St Bull statue

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over the next year. Our own DJIA peak price target is ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — December 18, 2012: Markets Open Higher, Rally on Budget Hopes (HPQ, KSU, SIRI, DUK, TSLA, DMND, SAFM, ORCL, FDX, NAV, NOK, ARB, NIEL, GALE, GTAT)

U.S. equity markets opened higher this morning on speculation -- and some reports -- that budget talks in the U.S. were making some progress. Asian markets clearly thought so, with ...
Read Full Story »
Bull and Bear figures

Today’s Market Winners and Losers

The stock market is up Tuesday, with the Dow Jones Industrial Average up 0.43%, the Nasdaq up 0.81%, and the S&P 500 up 0.62%. Today's winners include a pharmaceutical company ...
Read Full Story »
Wall St Bull statue

Today’s Market Winners and Losers

The stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.02%, the Nasdaq down 0.54% and the S&P 500 down 0.20%. Today's winners include a pharmaceutical company ...
Read Full Story »

Today’s Market Winners and Losers

The stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.11%, the Nasdaq down 0.37% and the S&P 500 up 0.05%. Today's sole winner reported earnings that fell in ...
Read Full Story »

Today’s Market Winners and Losers

As investors brace for Wednesday's congressional testimony from Federal Reserve Chairman Ben Bernanke, the stock market is up modestly. The Dow Jones Industrial Average is up 0.38%, the Nasdaq is up 0.86% ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AMZN, BAC, BA, SCHW, CME, FB, GALE, PCG, RF, STI, AMTD, TM, VLO, WSO, WNR, YUM)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday. Amazon.com, Inc. (NASDAQ: AMZN) removed from Conviction Buy List at Evercore. ...
Read Full Story »

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  ...
Read Full Story »

Drug Maker Prices Secondary Offering (GALE)

Biotech firm Galena Biopharma Inc. (NASDAQ: GALE) this morning priced a secondary offering of 8.5 million shares at $1.50/share, a discount of nearly 20% to last night’s closing price of ...
Read Full Story »

Blockbuster Opportunity for Galena Biopharma? GALE)

Galena Biopharma, Inc. (NASDAQ: GALE) is unknown to most investors out there.  The company recently had news about the initiation of its Phase III PRESENT trial for NeuVax (E75 peptide ...
Read Full Story »